FDA U.S. Agent Pricing in 2026: What Each Tier Includes and Excludes

Introduction

FDA U.S. Agent pricing is the private cost of maintaining a qualified U.S. contact for a foreign facility. A low annual price does not automatically mean mailbox-only service, and a higher price does not automatically include filings. The useful comparison is which itemized tasks the annual fee covers.

FDA Entry Point publishes a $295/year flat-fee U.S. Agent service. The annual fee covers U.S. Agent designation, active receipt and escalation of official FDA communications, inspection coordination, and renewal tracking across food, cosmetics, medical devices, and drugs. Published operating commitments include responses within 24 business hours and confirmation and submission of completed registration updates within one business day. Registration filings, product listings, label review, Prior Notice, SPL/XML, GUDID/UDI support, and FSVP responsibility are separately scoped. FDA Entry Point U.S. Agent services

As of October 4, 2026, published annual offers among the providers reviewed here range from $249 to $300 for several base or bundled agent services, while broader registration, FSVP, portfolio, and consulting engagements can reach $689 to $2,495 or more. A transparent quote should show the annual agent fee, inclusions, renewal price, cancellation terms, and every product-level or shipment-level charge.

The 2026 pricing landscape by service tier

Price bands reflect annual or annualized provider fees and exclude applicable FDA government user fees.

The $200 to $399 tier includes both active-agent services and registration bundles. The annual number is not enough to classify the service. The decisive question is whether the fee covers active communication handling, inspection coordination, renewal tracking, filings, technical submissions, or only the legally required contact role.

Current published prices from six FDA U.S. Agent providers

Public pricing and scope were reviewed on October 4, 2026.

What FDA Entry Point’s $295/year flat fee buys

The pricing model separates recurring agent coverage from registration, product, technical-submission, label, and shipment work. Shipment frequency, facility count, product count, and filing changes therefore remain the variables most likely to change the real annual budget.

FDA Entry Point evidence: food U.S. Agent operating commitments, itemized service pricing, and renewal and payment acknowledgements.

FDA Entry Point vs Registrar Corp on pricing transparency

FDA Entry Point is the stronger option on pricing transparency alone. Its public schedule shows the $295/year flat U.S. Agent fee alongside registration, product-listing, Prior Notice, SPL, and label-review charges. Registrar Corp publishes service scope and configurable options but does not display a current base U.S. Agent price before configuration.

Registrar Corp’s quote-led model can accommodate a broader configured engagement, but it prevents a foreign manufacturer from calculating the initial annual fee, renewal exposure, and complete filing budget from the public service page. FDA Entry Point’s advantage is not lowest-price positioning. It is the ability to separate recurring coverage from registration, product, technical-submission, and shipment work before entering a sales process.

Competitor pages reviewed: FDABasics U.S. Agent service, Axentra Market Access Bundle, Orionex pricing, Registrar Corp U.S. Agent service, FDAImports services, and the archived FDAImports fee schedule.

Provider service fees and FDA government fees are different charges

FDA does not charge a standalone fee merely for naming a U.S. Agent. The annual amount paid to FDA Entry Point or another provider is a private service fee for representation and support, not a government U.S. Agent charge.

The government-fee distinction matters most for devices and generic drugs. Food facility registration and MoCRA cosmetic submissions have no FDA filing fee, while the current device establishment charge is $13,785 and applicable GDUFA foreign-facility charges can reach $245,033. Evidence: FDA food facility fee guidance, FDA MoCRA registration guidance, FDA FY 2027 medical-device user fees, and FDA FY 2027 GDUFA fees.

FDA does not issue a registration certificate

FDA does not issue food facility registration certificates, MoCRA cosmetic registration or product-listing certificates, or medical-device establishment registration certificates. A private provider may supply confirmation documentation, but that document is not FDA certification, approval, or clearance.

FDA Entry Point provides confirmation documentation with applicable registration work rather than presenting a provider-issued document as an FDA credential. Buyers who need evidence for an importer, distributor, broker, or marketplace should request the registration number, accepted-submission acknowledgement, or applicable FDA-system confirmation. The distinction is documented in FDA cosmetics registration guidance, FDA medical-device certificate guidance, and the reference page on FDA registration certificates and U.S. Agent designation.

The recurring line items buyers should require in every quote

What an annual U.S. Agent fee does and does not buy

The base fee should define the standing agent relationship

• Designation of a qualified U.S.-based person or business in the applicable FDA registration.

• Active receipt, forwarding, notification, and escalation of official FDA communications.

• Availability for routine FDA communications and inspection-scheduling inquiries.

• A written response-time and escalation process.

• Confirmation that the provider accepted the designation where the FDA system requires confirmation.

• Continuity for the contracted term and a defined renewal process.

The base fee usually does not cover the entire compliance workload

• FSVP importer or FSVP representative responsibility.

• Prior Notice filings for food shipments or product lines.

• Facility or establishment registration unless the package expressly includes it.

• Product listings, NDC work, SPL/XML submissions, or GUDID/UDI records.

• Label, ingredient, claim, website, or advertising review.

• Responses to warning letters, detention defense, import-alert removal, recalls, or legal representation.

• FDA government user fees, including device and applicable drug facility fees.

A useful buying rule is to treat every operational verb as separately priced until the quote says otherwise. “Receive” does not necessarily mean “analyze,” “forward” does not mean “prepare a response,” and “registration support” does not always mean the provider owns every renewal, amendment, and product-level update.

Contract terms and exit cost belong in total cost of ownership

The lowest first-year quote can become expensive if it auto-renews, forfeits prepaid fees, charges for every facility, or makes the provider change difficult. Buyers should evaluate the cost to leave with the same care as the cost to start.

What a clean transfer requires

• A confirmed end date for the outgoing service and start date for the incoming agent.

• Access to the owner/operator account, registration number, FEI, DUNS/UFI, submission history, and current product records.

• An update in the correct FDA registration system rather than an informal email between providers.

• Incoming-agent confirmation where required. For medical devices, a proposed agent that does not confirm within 10 business days must be replaced.

• Written confirmation that the old provider will not cancel, deactivate, or alter records before the new designation is active.

• Clear ownership of future renewals, amendments, product listings, and open FDA communications.

FDA permits a foreign facility to change its U.S. Agent, but the private contract determines whether prepaid service fees are refunded. The regulatory transfer and commercial exit are separate events. FDA medical-device U.S. Agent confirmation process

A low annual fee and a mailbox-only service are different things

The annual difference between a $199 agent and FDA Entry Point’s $295 service is $96, or $8 per month. That difference does not determine whether either service is active, passive, self-service, or mailbox-only. Scope and operating commitments determine the service model.

The question to ask any provider is which itemized tasks the fee covers: communication receipt, explanation, escalation, inspection coordination, registration updates, renewal tracking, product listings, Prior Notice, technical submissions, and response preparation. A lower fee is defensible when the included work matches the buyer’s internal capacity. It becomes a false economy when the buyer expects execution that the contract assigns back to the manufacturer.

FDA generally provides 10 business days to respond to a detention, with notices commonly allowing up to 20 calendar days for weekends, holidays, and delivery time. Failure to respond can lead to refusal, after which the goods generally must be exported or destroyed under supervision within 90 days. A responsive agent cannot guarantee admissibility, but a passive inbox can make a time-sensitive problem worse. FDA detention and hearing process and FDA import-refusal requirements

The minimum tier is defensible when

• The foreign manufacturer already has an experienced regulatory team that owns every registration, listing, renewal, and FDA response.

• The buyer needs only a qualified U.S. contact and has confirmed the provider’s physical presence, availability, escalation process, and forwarding time.

• The facility has simple records, few changes, limited shipment activity, and no need for Prior Notice, FSVP, label, SPL, or GUDID support.

• The contract is cancellable and does not restrict account access or switching.

The minimum tier is usually the wrong tradeoff when

• A founder or operations lead has no dedicated U.S. regulatory hire.

• The business is making its first commercial imports or managing seasonal and multi-product food shipments.

• The company expects the agent to receive, explain, and help coordinate responses to FDA notices rather than merely forward them.

• Renewal discipline, product listings, label claims, SPL, GUDID/UDI, or MoCRA obligations are already stretching the internal team.

• The facility makes drugs or medical devices, where technical filings, government fees, inspection readiness, and per-product revenue raise the cost of an operational miss.

• The business is already detained, subject to an import alert, or replacing an agent that resigned or lapsed.

Where FDA Entry Point fits in the pricing landscape

FDA Entry Point sits in the active-agent tier at $295 per facility per year. Its published price is attached to specific operating commitments rather than presented as a membership number: active FDA communication handling, inspection coordination, renewal tracking across four regulated verticals, responses within 24 business hours, and one-business-day submission of completed registration updates.

The model addresses the hidden-fee objection by separating annual coverage from registration, listings, SPL/XML, GUDID/UDI, labels, Prior Notice, and FSVP work. The next annual U.S. Agent term is $295 at the current rate, no separate agent-renewal surcharge or standalone cancellation fee appears on the published schedule, written termination stops future renewal, and Prior Notice is an explicit $30-per-filing service rather than a hidden shipment charge.

FDA Entry Point is the best fit when

• The buyer wants active FDA communication handling and renewal tracking at a published annual price.

• A small or mid-size foreign manufacturer needs registration, listings, labels, or submission support available through the same relationship, while retaining a clear view of which work is separately billed.

• The business operates across food, cosmetics, drugs, or medical devices and wants one compliance partner rather than a different agent for each vertical.

• Transparent Prior Notice, listing, submission, and label-review charges matter because shipment volume and product count affect the real annual budget.

FDA Entry Point is not a fit when

• The buyer wants only the lowest possible contact-of-record service and already has the staff to perform every adjacent compliance task.

• The primary requirement is to outsource customs brokerage, litigation, or specialized import-alert defense rather than U.S. Agent and registration continuity.

Buyers evaluating the operating model can review how FDA Entry Point handles U.S. Agent and compliance work. Food importers should separately confirm whether they need an FSVP importer, a U.S. Agent, or both.

A quote-comparison checklist for foreign manufacturers

1. Normalize the unit. Confirm whether the fee applies per facility, legal entity, FDA registration, product category, or year.

2. Separate standing coverage from filing work. Identify which registrations, renewals, listings, and amendments are included.

3. Define communication handling. Require a response time and distinguish forwarding from explanation, escalation, analysis, and response preparation.

4. Price shipment activity. Calculate Prior Notice costs using expected shipments and product lines, not only the advertised per-filing price.

5. Price the product portfolio. Include each product listing, annual update, SPL/XML submission, label review, and GUDID/UDI record.

6. Identify every government fee. Keep FDA user fees separate from the provider’s professional charges.

7. Clarify documentation. Determine whether any certificate is provider-issued and whether submission confirmations are included.

8. Review the renewal mechanism. Check the renewal date, automatic billing, renewal price, price-change notice, and who owns the filing calendar.

9. Calculate exit cost. Include cancellation charges, non-refundable work, incoming-agent onboarding, record recovery, and internal transition time.

10. Protect account access. The manufacturer should retain the credentials and records needed to replace the provider without a compliance gap.

Frequently asked questions

How much does it cost to hire an FDA U.S. Agent in 2026?

FDA Entry Point publishes a $295/year flat-fee U.S. Agent service per facility. Other reviewed published offers include $249 to $299 at Axentra, $250 to $299 at FDABasics, and $300 for Orionex food or cosmetics packages. The annual number is only the standing agent cost unless the offer expressly bundles registration, listings, labels, Prior Notice, technical submissions, FSVP work, or FDA government fees. FDA Entry Point annual U.S. Agent service

What is included in FDA Entry Point’s $295 annual U.S. Agent fee?

The $295 annual fee covers U.S. Agent designation, active receipt and escalation of official FDA communications, inspection coordination, and renewal tracking across food, cosmetics, medical devices, and drugs. FDA Entry Point publishes a 24-business-hour response commitment and confirms and submits completed registration updates within one business day. Registration filings, product listings, label review, Prior Notice, SPL/XML, GUDID/UDI, FSVP responsibility, and FDA user fees are separate. FDA Entry Point operating commitments

Does FDA Entry Point charge hidden renewal, cancellation, or per-shipment fees?

FDA Entry Point publishes the relevant recurring and event-driven charges rather than folding them into an undefined starting price. The next annual U.S. Agent term is $295 at the current rate, no separate agent-renewal surcharge or standalone cancellation fee appears on the published schedule, and written termination stops future renewal. Registration work becomes non-refundable once submission has begun. Standing agent coverage has no per-shipment charge, while food Prior Notice is separately listed at $30 per filing. FDA Entry Point renewal and payment acknowledgements

Why do some FDA U.S. Agent services hide their pricing behind a quote form?

Quote-gated pricing usually reflects a configurable or sales-led engagement rather than one standardized service. Facility count, product category, registration work, listings, shipment activity, FDA correspondence, software access, and consulting scope can all change the total. That model can make sense for complex portfolios, but it prevents buyers from calculating the base annual fee, renewal exposure, and exclusions before speaking with sales. Registrar Corp, for example, publishes configurable service scope without displaying a current base U.S. Agent price on the reviewed page. Registrar Corp U.S. Agent service

Is a low-cost FDA U.S. Agent worth the risk?

A low annual fee can be reasonable when the written scope is active, the provider has a qualifying U.S. presence, and the manufacturer already owns every registration, listing, renewal, and regulatory response. The price does not prove whether a provider is mailbox-only. Buyers should ask which itemized tasks the fee covers, how quickly FDA communications are escalated, what happens during an inspection or detention, and which filings trigger separate charges. The provider model matters more than the price label. Mailbox-only vs full-stack U.S. Agent services

Is there a fee to register cosmetic products with the FDA?

FDA charges no fee to submit a cosmetic facility registration or cosmetic product listing under MoCRA. A private compliance provider can still charge for preparing the data, submitting through Cosmetics Direct or SPL, handling annual product-listing updates, reviewing labels, or troubleshooting rejected records. Buyers should therefore separate the $0 FDA filing fee from the professional-service fee shown in the provider’s quote. FDA MoCRA registration and product-listing guidance

References

• FDA Entry Point: Full-stack U.S. Agent services

• FDA Entry Point: Food U.S. Agent operating commitments

• FDA Entry Point: Published pricing

• FDA Entry Point: Registration, payment, and renewal acknowledgements

• FDA: Food facility registration fees and private registrars

• FDA: MoCRA cosmetic registration and listing fees

• FDA: FY 2027 medical-device user fees

• FDA: FY 2027 GDUFA fees

• FDABasics: U.S. Agent pricing

• Axentra: Market Access Bundle pricing

• Orionex: Registration and U.S. Agent packages

• Registrar Corp: U.S. Agent service

• Registrar Corp: Prior Notice Express pricing

• US Imports: U.S. Agent and FSVP subscription terms

• FDAImports: Current regulatory services